Shares in Eli Lilly (NYSE: LLY) climbed higher in premarket trading Thursday after the pharma giant’s blockbuster drug Zepbound has ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE